Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Change in Inventory: 2012-2018

Historic Change in Inventory for Theravance Biopharma (TBPH) over the last 7 years, with Dec 2018 value amounting to $1.6 million.

  • Theravance Biopharma's Change in Inventory fell 75.17% to $1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was $1.6 million, marking a year-over-year decrease of 77.69%. This contributed to the annual value of $1.6 million for FY2018, which is 77.69% down from last year.
  • Per Theravance Biopharma's latest filing, its Change in Inventory stood at $1.6 million for FY2018, which was down 77.69% from $7.3 million recorded in FY2017.
  • In the past 5 years, Theravance Biopharma's Change in Inventory registered a high of $7.3 million during FY2017, and its lowest value of -$1.0 million during FY2015.
  • Moreover, its 3-year median value for Change in Inventory was $3.2 million (2016), whereas its average is $4.0 million.
  • In the last 5 years, Theravance Biopharma's Change in Inventory plummeted by 115.54% in 2015 and then surged by 408.93% in 2016.
  • Over the past 5 years, Theravance Biopharma's Change in Inventory (Yearly) stood at $6.6 million in 2014, then slumped by 115.54% to -$1.0 million in 2015, then soared by 408.93% to $3.2 million in 2016, then surged by 129.45% to $7.3 million in 2017, then tumbled by 77.69% to $1.6 million in 2018.